56 Biggest Movers From Yesterday

Gainers

• Aptevo Therapeutics Inc. APVO shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
• Pasithea Therapeutics Corp. KTTA shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
• Qualigen Therapeutics, Inc. QLGN surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
• Vallon Pharmaceuticals, Inc. VLON jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
• Petros Pharmaceuticals, Inc. PTPI gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
• iSpecimen Inc. ISPC gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
• MediciNova, Inc. MNOV surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
• Clarus Therapeutics Holdings, Inc. CRXT gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
• Esperion Therapeutics, Inc. ESPR surged 40.7% to settle at $10.02
• Sunlands Technology Group STG rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
• Gracell Biotechnologies Inc. GRCL rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
• Dycom Industries, Inc. DY climbed 19.7% to close at $99.91 following upbeat Q3 results.
• Enanta Pharmaceuticals, Inc. ENTA gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
• BM Technologies, Inc. BMTX jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
• Unicycive Therapeutics, Inc. UNCY rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
• Reliance Global Group, Inc. RELI gained 14.7% to settle at $2.42.
• Armata Pharmaceuticals Inc. ARMP jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
• QIWI plc QIWI rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
• Movado Group, Inc. MOV gained 11.7% to close at $44.58 following Q3 results.
• Dollar Tree, Inc. DLTR surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
• Kosmos Energy Ltd. KOS gained 9.1% to close at $3.71.
• Burlington Stores, Inc. BURL surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
• XPeng Inc. XPEV jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
• XL Fleet Corp. XL gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
• Western Digital Corporation WDC gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
• Soligenix, Inc. SNGX rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
• Tonix Pharmaceuticals Holding Corp. TNXP shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.

Check out these big penny stock gainers and losers

Losers

• Society Pass Incorporated SOPA dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
• Longeveron Inc. LGVN shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
• Enjoy Technology, Inc. ENJY fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
• Greenland Technologies Holding Corporation GTEC fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
• Genius Sports Limited GENI fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
• Grom Social Enterprises, Inc. GROM fell 22.2% to settle at $2.25.
• Entrada Therapeutics, Inc. TRDA dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
• Vinco Ventures, Inc. BBIG declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
• Local Bounti Corp. LOCL dipped 19.1% to settle at $8.01.
• Aurora Innovation, Inc. AUR fell 18.7% to close at $12.15.
• Sarcos Technology and Robotics Corporation STRC dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
• Benson Hill, Inc. BHIL dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
• Science 37 Holdings, Inc. SNCE fell 17.1% to close at $9.43.
• PainReform Ltd. PRFX fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
• Femasys Inc. FEMY dipped 16.8% to settle at $4.06.
• Design Therapeutics, Inc. DSGN fell 16.3% to close at $17.00.
• Momentus Inc. MNTS dropped 15.5% to settle at $6.88.
• Tyra Biosciences, Inc. TYRA declined 15.5% to settle at $19.34.
• Zoom Video Communications, Inc. ZM fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
• GameStop Corp. GME dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
• Abercrombie & Fitch Co. ANF fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
• Best Buy Co., Inc. BBY fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
• The Lovesac Company LOVE fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
• Urban Outfitters, Inc. URBN fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
• Adamis Pharmaceuticals Corporation ADMP fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
• Relay Therapeutics, Inc. RLAY fell 7.8% to close at $31.61.
• Central Garden & Pet Company CENTA dropped 6.3% to close at $46.59 following Q4 results.
• Hibbett, Inc. HIBB dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
• DICK'S Sporting Goods, Inc. DKS declined 4.1% to close at $134.55 following Q3 results.